
|Videos|October 6, 2017
What Are the Results of the REVIVE-2 Trial?
Author(s)Contagion® Editorial Staff
David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.
Advertisement
David Huang, PhD, MD, chief medical officer at Motif Bio, shares the recent results of the REVIVE-2 trial.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of November 29 - December 5
2
Early 2025 Influenza Vaccination Trends Following Prior Season and H3N2 Start
3
ACIP Votes on Hepatitis B Vaccine Marks More Confusion, No Supportive Safety Data, and Uncertainty of Public Health Policy
4
Call to Consider Off-Label COVID-19 Vaccination for Children
5

















































































































































































































































































